Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126168131 | 12616813 | 1 | I | 201008 | 20160725 | 20160802 | 20160802 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-48872BP | BOEHRINGER INGELHEIM | 65.72 | YR | F | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126168131 | 12616813 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 20520 | TABLET | ||||||||||
| 126168131 | 12616813 | 2 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 20520 | ||||||||||||
| 126168131 | 12616813 | 3 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126168131 | 12616813 | 1 | Flatulence |
| 126168131 | 12616813 | 2 | Irritable bowel syndrome |
| 126168131 | 12616813 | 3 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126168131 | 12616813 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126168131 | 12616813 | Gastric haemorrhage | |
| 126168131 | 12616813 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |